In the intricate world of pharmaceutical manufacturing, the quality and availability of key intermediates are paramount. One such compound that plays a vital role is 4-(Phthalimido)-Cyclohexanone, identified by its CAS number 104618-32-8. This specialized chemical is not merely a component; it's a foundational element in the synthesis of critical medications, most notably Pramipexole, a drug essential for managing conditions like Parkinson's disease and restless legs syndrome.

The journey from raw materials to life-saving drugs involves complex chemical transformations, and intermediates like 4-(Phthalimido)-Cyclohexanone are the linchpins of these processes. Its chemical structure, C14H13NO3, and molecular weight of 243.25800, hint at its suitability for precise chemical reactions. Manufacturers and researchers rely on a consistent supply of high-purity intermediates to ensure the efficacy, safety, and regulatory compliance of their final pharmaceutical products. The established purity of u226598% for 4-(Phthalimido)-Cyclohexanone is a testament to its value in sensitive pharmaceutical applications.

Understanding the chemical properties of 4-(Phthalimido)-Cyclohexanone reveals why it's so sought after. With a density of 1.357 g/cmu00b3, it indicates a compact molecular arrangement. Its high boiling point of approximately 409.96u00b0C at standard atmospheric pressure suggests significant thermal stability, which is advantageous during various synthesis steps. Furthermore, a flash point of 191.1u00b119.1 u00b0C points to moderate volatility, making it manageable in production environments. The appearance of the compound as a white to off-white powder further simplifies its handling and quality assessment.

The primary application driving the demand for 4-(Phthalimido)-Cyclohexanone is its indispensable role in the Pramipexole synthesis pathways. Pramipexole, a dopamine agonist, is a cornerstone therapy for neurological disorders. The reliable supply of intermediates like this is crucial for pharmaceutical companies seeking to maintain efficient production schedules and meet global healthcare needs. For businesses looking to source pharmaceutical intermediates, partnering with reputable manufacturers ensures access to materials that adhere to stringent quality control measures.

In the competitive landscape of fine chemical manufacturing, the ability to produce and supply high-quality intermediates reliably is a key differentiator. 4-(Phthalimido)-Cyclohexanone exemplifies this need, bridging the gap between basic chemistry and advanced pharmaceutical production. Its consistent availability and quality empower drug development and manufacturing, ultimately contributing to better patient outcomes worldwide.